Bioheart, Inc. Partners With Life Technologies Corporation to Offer Myoblast Cell Products to the Research Market

SUNRISE, Fla., Dec. 18, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) and Life Technologies Corporation (Nasdaq:LIFE) have entered into a global distribution and OEM agreement to sell myoblast cell-based research products to life science researchers. Life Technologies will offer Bioheart's myoblast stem cell products to the research community so that they may accelerate the development of myoblast stem cell applications.